Joel Outten's Colleagues at Blade Therapeutics
Daven Mody
Senior Vice President, Global Regulatory Affairs, Quality, and Safety / Project Team Lead
Bassem Elmankabadi
Senior Vice President, Clinical Development (Fibrosis-Oncology and Neurodegenerative)
Joel Outten's Contact Details
650-278-4291
San Francisco,California,United States
Blade Therapeutics
Joel Outten's Company Details
Blade Therapeutics is a biopharmaceutical company focused on developing cutting-edge treatments for debilitating, incurable fibrotic and neurodegenerative diseases that impact millions of people worldwide. We are a leader in novel biological pathways – including autotaxin / LPA and calpain biology – that are foundational to cell- and tissue-damage responses resulting from protein deposition or aggregation associated with fibrotic and neurodegenerative diseases. Our focused approach offers the potential to produce disease-modifying, life-saving therapies. Since our founding in 2015, the Company has assembled critical leadership expertise supplemented by a world-class network of scientific, pharmaceutical and clinical advisors to enable efficient and successful drug development.Blade is advancing a differentiated pipeline of oral, small-molecule therapies that include a non-competitive autotaxin inhibitor and inhibitors of dimeric calpains designed for the potential treatment of lung, liver and cardiac fibrosis or neurodegenerative diseases.